直管与Valsalva移植物行主动脉瓣再植入的中期结局比较
该研究比较了直管与Valsalva移植物行保留主动脉瓣的主动脉根部再植入(VSRR)的中期血流动力学性能和耐久性。2000年至2023年间1495例无内膜炎成人接受VSRR,倾向匹配365对患者。结果显示两种移植物中期耐久性和血流动力学表现均良好,Valsalva组再手术风险较高可能反映病例复杂性和技术难度。
要点
- 直管与Valsalva移植物行VSRR的中期血流动力学和耐久性相当
- 直管组主动脉瓣再手术免除率总体更高(96% vs 94%,P=.045)
- Valsalva组再手术风险较高可能与合并主动脉瓣修复比例更高有关
核心结论
- VSRR无论使用直管还是Valsalva移植物均显示良好的中期耐久性和血流动力学性能。
- Valsalva移植物再手术风险较高可能反映病例组合和技术复杂性而非移植物本身。
研究设计与样本
- 回顾性队列研究,纳入2000年1月1日至2023年12月1日在Cleveland Clinic接受VSRR的1495例无内膜炎成人。
- 838例(56%)接受直管移植物,657例(44%)接受Valsalva移植物,倾向匹配365对患者(730例)进行比较。
主要发现
- 匹配后手术死亡率直管组0.56% vs Valsalva组0.28%(P=.56)。
- 5年时平均主动脉瓣压差6.6 vs 6.3 mm Hg(P=.46),中重度主动脉瓣反流患病率12% vs 9.1%(P=.38)。
- 直管组总体主动脉瓣再手术免除率更高(96% vs 94%,P=.045),结构性瓣膜退化再手术免除率也更高(98% vs 95%,P=.019),5年时再手术率分别为0.27%/年 vs 0.83%/年。
- Valsalva组合并主动脉瓣修复更常见(37% vs 44%,P=.059),合并修复与更高的再手术风险相关(P=.0023);调整合并修复的混杂效应后,再手术风险P=.082。
临床怎么用
- 对于需行VSRR的患者,直管和Valsalva移植物均可选择,中期耐久性良好。
- Valsalva移植物再手术风险较高可能源于病例复杂性,应结合患者具体解剖和合并修复需求个体化选择移植物。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To compare midterm hemodynamic performance and durability of valve-sparing aortic root reimplantation (VSRR) using a Straight graft versus Valsalva graft. METHODS: From January 1, 2000, to December 1, 2023, 1495 adults without endocarditis underwent VSRR at Cleveland Clinic, of whom 838 (56%) received a Straight graft and 657 (44%) a Valsalva graft. Mean aortic valve gradient, aortic regurgitation grade, aortic valve reoperation, and survival were compared in 365 propensity-matched patient pairs (730 patients). RESULTS: After matching (Straight graft vs Valsalva), operative mortality was 0.56% versus 0.28% (P = .56). At 5 years, mean aortic valve gradients were 6.6 versus 6.3 mm Hg (P = .46) and prevalence of moderate or severe aortic regurgitation 12% versus 9.1% (P = .38). Straight grafts were associated with higher freedom from aortic valve reoperation overall (96% vs 94%, P = .045) and for structural valve deterioration (98% vs 95%, P[constant phase] = .019), at a rate of 0.27%/year versus 0.83%/year at 5 years. Concomitant aortic valve repair was more prevalent in patients receiving a Valsalva graft (37% vs 44%, P = .059), which carried a higher risk of reoperation (P[log-rank] = .0023; after adjusting for the confounding effect of concomitant aortic valve repair, P for risk of reoperation was .082). CONCLUSIONS: Despite its increasing use in patients with more complexity and greater risk, VSRR demonstrates excellent midterm durability and hemodynamic performance, regardless of graft type. Greater risk of reoperation with Valsalva grafts likely reflects case mix and technical complexity.
引用
- Tabrizi NS, Rosinski BF, Umana H, et al. Midterm outcomes after aortic valve reimplantation with a Straight versus Valsalva graft. J Thorac Cardiovasc Surg. 2026. PMID: 42744046. doi:10.1016/j.jtcvs.2026.08.029
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。